As expected, comparing the overall prevalence by epidemiological wave, we observed an increasing trend, with 16.1% in the first wave, 35.5% in the second and 46.6 in the third (Table 3 ).
← all excerpts
SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City.
1
—
—